Clinical Relevance of 5-HT3 Receptors

Neuroanatomical Distribution and Clinical Relevance

• The presence of 5-HT3 receptors in brainstem neurons is consistent with their role in functions like nausea and vomiting control, as evidenced by the clinical use of 5-HT3 antagonists as antiemetics, according to the National Comprehensive Cancer Network 1, 2
• 5-HT3 receptor antagonists (such as ondansetron, granisetron, and palonosetron) are clinically important for controlling chemotherapy-induced nausea and vomiting, as recommended by the National Comprehensive Cancer Network 1, 2
• These antagonists block the rapid excitatory response mediated by 5-HT3 receptors in the chemoreceptor trigger zone and vagal afferents, providing a mechanism for controlling nausea and vomiting 2, 3

Comparison with Other Receptor Subtypes

• 5-HT1A, 5-HT2A, 5-HT4, and 5-HT7 receptors all function through G-protein coupled mechanisms that involve second messengers, resulting in slower signaling kinetics, as described in the European Journal of Nuclear Medicine and Molecular Imaging 4, 5